Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Leen Ann M.
Chief Scientific Officer at Kalaris Therapeutics. Filing since 16 Feb 2021.
CIK 0001763026
Company
Date
Role
Action
Shares
Amount
Of holding
KLRS
Kalaris Therapeutics, Inc.
16 Nov 2021
Chief Scientific Officer
Sold, plan not stated
100
$2.18K
0.0%
KLRS
Kalaris Therapeutics, Inc.
15 Nov 2021
Chief Scientific Officer
Sold, plan not stated
6,122
$134.17K
0.3%
KLRS
Kalaris Therapeutics, Inc.
12 Nov 2021
Chief Scientific Officer
Sold, plan not stated
14,766
$329.22K
0.6%
KLRS
Kalaris Therapeutics, Inc.
10 May 2021
Chief Scientific Officer
Sold, plan not stated
150,000
$3.41M
6.1%
KLRS
Kalaris Therapeutics, Inc.
16 Mar 2021
Chief Scientific Officer
Sold, plan not stated
3,025
$90.75K
0.1%
KLRS
Kalaris Therapeutics, Inc.
1 Mar 2021
Chief Scientific Officer
Sold, plan not stated
9,518
$368.33K
0.4%
KLRS
Kalaris Therapeutics, Inc.
23 Feb 2021
Chief Scientific Officer
Sold, plan not stated
4,199
$165.88K
0.2%
KLRS
Kalaris Therapeutics, Inc.
22 Feb 2021
Chief Scientific Officer
Sold, plan not stated
5,706
$242.88K
0.2%
KLRS
Kalaris Therapeutics, Inc.
19 Feb 2021
Chief Scientific Officer
Sold, plan not stated
7,541
$314.87K
0.3%
KLRS
Kalaris Therapeutics, Inc.
18 Feb 2021
Chief Scientific Officer
Sold, plan not stated
2,700
$110.19K
0.1%
KLRS
Kalaris Therapeutics, Inc.
17 Feb 2021
Chief Scientific Officer
Sold, plan not stated
2,286
$92.47K
0.1%
KLRS
Kalaris Therapeutics, Inc.
16 Feb 2021
Chief Scientific Officer
Sold, plan not stated
3,050
$127.73K
0.1%
12 decisions on file.
